These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25955251)

  • 1. Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola A; García-Dorado D
    Coron Artery Dis; 2015 Aug; 26(5):367-8. PubMed ID: 25955251
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Lopes RD; Leonardi S; Wojdyla DM; Vora AN; Thomas L; Storey RF; Vinereanu D; Granger CB; Goodman SG; Aronson R; Windecker S; Thiele H; Valgimigli M; Mehran R; Alexander JH
    Circulation; 2020 Mar; 141(9):781-783. PubMed ID: 31707833
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
    Paikin JS; Mehta SR; Eikelboom JW
    Med J Aust; 2010 May; 192(9):487-8. PubMed ID: 20438416
    [No Abstract]   [Full Text] [Related]  

  • 7. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple Antithrombotic Therapy - Always One Too Many?
    Fukaya H; Ako J
    Circ J; 2016; 80(2):316-7. PubMed ID: 26763466
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple therapy for percutaneous coronary intervention in atrial fibrillation: standard of care, or a nightmare soon to end?
    Verheugt FW
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S332-5. PubMed ID: 26149044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.
    Enomoto Y; Iijima R; Tokue M; Ito N; Nagashima Y; Araki T; Yamazaki K; Utsunomiya M; Hori M; Itaya H; Shiba M; Hara H; Nakamura M; Sugi K
    Cardiovasc Interv Ther; 2014 Jul; 29(3):193-9. PubMed ID: 24366503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Anticoagulation in Patients with Atrial Fibrillation Undergoing PCI: Double or Triple Therapy?
    Peterson BE; Bhatt DL
    Curr Cardiol Rep; 2018 Sep; 20(11):110. PubMed ID: 30259187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.
    Leggio M; Fusco A; Severi P; Lombardi M; Caldarone E; D'Emidio S; Armeni M; Mereu D; Bendini MG; Mazza A
    Drugs; 2018 Sep; 78(13):1309-1319. PubMed ID: 30132258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran versus warfarin in patients with atrial fibrillation.
    Tomoda H
    N Engl J Med; 2009 Dec; 361(27):2671-2; author reply 2674-5. PubMed ID: 20050382
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple therapy in hospitalized patients: facts and controversies.
    Srour JF; Smetana GW
    J Hosp Med; 2011 Nov; 6(9):537-45. PubMed ID: 21374797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual therapy with direct oral anticoagulants significantly increases the risk of stent thrombosis compared to triple therapy.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):128-129. PubMed ID: 31309231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.